SEC 13F Intelligence

Atlas Venture Life Science Advisors, LLC / REPL

Atlas Venture Life Science Advisors, LLC’s Replimune Group Inc Position

Does Atlas Venture Life Science Advisors, LLC own Replimune Group Inc (REPL)? Not currently — the last reported position was 2.10M shares worth $19M in Q2 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$19M
Q2 2024
Shares
2.10M
% of Portfolio
+1.99%
Quarters Held
10
position exited

Position History REPL

Reported value by quarter
Q1 ’22: $54MQ1 ’22Q2 ’22: $56MQ3 ’22: $54MQ3 ’22Q4 ’22: $57MQ1 ’23: $37MQ1 ’23Q2 ’23: $49MQ3 ’23: $36MQ3 ’23Q4 ’23: $18MQ1 ’24: $17MQ1 ’24Q2 ’24: $19Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q2 20242.10M$19M+1.99%
Q1 20242.10M$17M+1.58%
Q4 20232.10M$18M+2.11%
Q3 20232.10M$36M+5.56%
Q2 20232.10M$49M+6.06%
Q1 20232.10M$37M+5.02%
Q4 20222.10M$57M+6.87%
Q3 20223.11M$54M+5.92%
Q2 20223.21M$56M+9.38%
Q1 20223.21M$54M+6.89%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Atlas Venture Life Science Advisors, LLC’s full portfolio or all institutional holders of REPL.